Reaction Details Report a problem with these data
Target
Arginase-1
Ligand
BDBM642287
Substrate
n/a
Meas. Tech.
Inhibition of Arginase
IC50
5.50±n/a nM
Citation
 Kurhade, S; Dömling, A Arginase inhibitors US Patent  US11845767 Publication Date 12/19/2023 
Target
Name:
Arginase-1
Synonyms:
ARG1 | ARGI1_HUMAN | Liver-type arginase | Type I arginase
Type:
PROTEIN
Mol. Mass.:
34737.53
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978893
Residue:
322
Sequence:
MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK
  
Inhibitor
Name:
BDBM642287
Synonyms:
(5-amino-5-(1-(2-(((6-chloropyridin-3- yl)methyl)amino)-2-oxoethyl)-1H-tetrazol- 5-yl)pentyl)boronic acid | US11845767, Example 332
Type:
Small organic molecule
Emp. Form.:
C14H21BClN7O3
Mol. Mass.:
381.626
SMILES:
NC(CCCCB(O)O)c1nnnn1CC(=O)NCc1ccc(Cl)nc1
Structure:
Search PDB for entries with ligand similarity: